drugset / Trial / NCT02052882

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

NCT02052882

NaSingle-groupOpen-labelTreatment

Summary

This study is to determine if using weekly romiplostim injections will improve the patient's platelet count more effectively than simply waiting for the platelets to improve on its own, and if romiplostim will also allow the patient to receive at least 2 further cycles of chemotherapy without thrombocytopenia.

Timeline

Start
2014-01-30
Primary completion
2023-11-13
Completion
2023-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Romiplostim Peptide 2 ug/kg Subcutaneous

Indications